Expression of NOTCH1 in thyroid cancer is mostly restricted to papillary carcinoma.

NOTCH1 immunohistochemistry papillary carcinoma thyroid

Journal

Endocrine connections
ISSN: 2049-3614
Titre abrégé: Endocr Connect
Pays: England
ID NLM: 101598413

Informations de publication

Date de publication:
01 Aug 2019
Historique:
received: 26 06 2019
accepted: 02 07 2019
pubmed: 3 7 2019
medline: 3 7 2019
entrez: 3 7 2019
Statut: ppublish

Résumé

The NOTCH signaling is an evolutionarily conserved signaling pathway that regulates cell-cell interactions. NOTCH family members play a fundamental role in a variety of processes during development in particular in cell fate decisions. As other crucial factors during embryogenesis, NOTCH signaling is aberrantly reactivated in cancer where it has been linked to context-dependent effects. In thyroid cancer, NOTCH1 expression has been associated to aggressive features even if its in vivo expression within the entire spectrum of thyroid tumors has not definitively established. A series of 106 thyroid specimens including non-neoplastic lesions, benign and malignant tumors of common and rare histotypes, were investigated by immunohistochemistry to assess NOTCH1 expression. Extent of positivity and protein localization were investigated and correlated with clinical and morphological parameters. NOTCH1 positivity was predominantly associated with papillary carcinomas and only occasionally found in follicular carcinomas. Poorly differentiated and undifferentiated thyroid carcinomas showed only a partial positivity. NOTCH1 expression pattern also seemed differently distributed according to histotype. Our data confirm a role of NOTCH1 in thyroid cancer and highlight for the first time the specific involvement of this pathway in papillary carcinomas. Our data also indicate that other thyroid malignancies do not rely on NOTCH1 signaling for development and progression.

Identifiants

pubmed: 31265994
doi: 10.1530/EC-19-0303
pii: EC-19-0303
pmc: PMC6652246
doi:
pii:

Types de publication

Journal Article

Langues

eng

Pagination

1089-1096

Références

Cancer Res. 2014 Nov 1;74(21):6364-74
pubmed: 25164006
Am J Surg Pathol. 1999 Jun;23(6):678-85
pubmed: 10366150
Cell Mol Life Sci. 2009 May;66(10):1631-46
pubmed: 19165418
Nat Rev Cancer. 2017 Mar;17(3):145-159
pubmed: 28154375
Nat Rev Cancer. 2003 Oct;3(10):756-67
pubmed: 14570040
Mol Cancer Ther. 2013 Jul;12(7):1276-87
pubmed: 23594881
Mol Cancer Ther. 2009 Feb;8(2):350-6
pubmed: 19190121
J Exp Med. 2011 Sep 26;208(10):1931-5
pubmed: 21948802
Semin Cell Dev Biol. 2012 Jun;23(4):473-80
pubmed: 22373641
Biomed Rep. 2016 Sep;5(3):344-348
pubmed: 27602214
PLoS One. 2017 Feb 16;12(2):e0167782
pubmed: 28207739
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S497-504
pubmed: 24419754
Cancer Cell Int. 2019 Jan 03;19:5
pubmed: 30622441
J Clin Endocrinol Metab. 2012 Oct;97(10):E2006-15
pubmed: 22821892
Clin Cancer Res. 2016 Jul 15;22(14):3582-92
pubmed: 26847059
Annu Rev Pathol. 2017 Jan 24;12:245-275
pubmed: 27959635
Semin Cancer Biol. 2004 Oct;14(5):320-8
pubmed: 15288257
J Clin Endocrinol Metab. 2008 Oct;93(10):4080-7
pubmed: 18664540
Pediatr Blood Cancer. 2012 May;58(5):682-9
pubmed: 21744479
Onco Targets Ther. 2016 Mar 15;9:1519-23
pubmed: 27042120
Contemp Oncol (Pozn). 2016;20(4):267-72
pubmed: 27688721
Front Oncol. 2014 Dec 04;4:345
pubmed: 25538890
Cell Death Dis. 2018 Aug 29;9(9):871
pubmed: 30158530
Oncogene. 2008 Sep 1;27(38):5132-7
pubmed: 18758482
Thyroid. 2011 Dec;21(12):1323-30
pubmed: 22066479
Stem Cell Investig. 2018 Mar 12;5:5
pubmed: 29682512
Transl Oncol. 2013 Apr;6(2):197-205
pubmed: 23544172
Oncotarget. 2016 May 17;7(20):29804-23
pubmed: 26934331
Cancer Res Treat. 2017 Apr;49(2):509-517
pubmed: 27586674
Cancer Res. 2003 Dec 1;63(23):8323-9
pubmed: 14678992
Genes Cancer. 2011 Dec;2(12):1106-16
pubmed: 22866202

Auteurs

Simonetta Piana (S)

Pathology Unit, Azienda USL - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Eleonora Zanetti (E)

Pathology Unit, Azienda USL - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Alessandra Bisagni (A)

Pathology Unit, Azienda USL - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Alessia Ciarrocchi (A)

Laboratory of Translational Research, Azienda USL - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Davide Giordano (D)

Otolaryngology Unit, Azienda USL - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Federica Torricelli (F)

Laboratory of Translational Research, Azienda USL - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Teresa Rossi (T)

Laboratory of Translational Research, Azienda USL - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Moira Ragazzi (M)

Pathology Unit, Azienda USL - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Classifications MeSH